Furthermore, recent data suggests that local inflammation, tumor immune infiltration and tumor programmed death-ligand 1 (PD-L1) expression seem to be associated with response rate and survival in PD-1 inhibition in HNSCC [6]. Here, PDCD1 is linked to head and neck squamous cell carcinoma.